93 related articles for article (PubMed ID: 3821913)
21. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.
Rosenblum MG; Murray JL; Haynie TP; Glenn HJ; Jahns MF; Benjamin RS; Frincke JM; Carlo DJ; Hersh EM
Cancer Res; 1985 May; 45(5):2382-6. PubMed ID: 3986780
[TBL] [Abstract][Full Text] [Related]
23. The use of daunomycin-antibody immunoconjugates in managing soft tissue sarcomas: nude mouse xenograft model.
Stastny JJ; Das Gupta TK
Cancer Res; 1993 Dec; 53(23):5740-4. PubMed ID: 8242630
[TBL] [Abstract][Full Text] [Related]
24. Use of new heterobifunctional reagent for radiometallic labeling of antibodies.
Wang TS; Ng AK; Alsedairy S; Fawwaz RA; Hardy MA; Alderson PO
NCI Monogr; 1987; (3):145-8. PubMed ID: 3821912
[TBL] [Abstract][Full Text] [Related]
25. Tumor uptake and metabolism of copper-67-labeled monoclonal antibody chCE7 in nude mice bearing neuroblastoma xenografts.
Novak-Hofer I; Zimmermann K; Maecke HR; Amstutz HP; Carrel F; Schubiger PA
J Nucl Med; 1997 Apr; 38(4):536-44. PubMed ID: 9098198
[TBL] [Abstract][Full Text] [Related]
26. Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.
Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
J Nucl Med; 1998 Mar; 39(3):476-84. PubMed ID: 9529295
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of NR-LU-10 with the Neoprobe gamma detector in a mouse model.
Lange MK; Sandhu A; Sampsel J; Hinkle G; Ignaszewski J; Martin E; Sandhu P; Martin EW
J Surg Res; 1993 Aug; 55(2):205-13. PubMed ID: 8412101
[TBL] [Abstract][Full Text] [Related]
28. Comparison of multiple bolus and continuous injections of 131I-labeled CC49 for therapy in a colon cancer xenograft model.
Buchsbaum DJ; Khazaeli MB; Mayo MS; Roberson PL
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3153s-3159s. PubMed ID: 10541357
[TBL] [Abstract][Full Text] [Related]
29. Kinetics of 111In-bleomycin and 111 In-chlorides in mice.
Konikowski T; Haynie TP; Glenn HJ
J Nucl Med; 1975 Aug; 16(8):738-43. PubMed ID: 51922
[TBL] [Abstract][Full Text] [Related]
30. The use of indium-111 for studies of cytotoxicity mediated by lymphocytes or by antibodies and complement.
Ferluga J; Allison AC; Thakur ML
J Clin Lab Immunol; 1979 Feb; 1(4):339-42. PubMed ID: 501729
[TBL] [Abstract][Full Text] [Related]
31. Comparison of gallium-67 versus indium-111 monoclonal antibody (96.5, ZME-018) in detection of human melanoma in athymic mice.
Chan SM; Hoffer PB; Maric N; Zoghbi SS; Kirkwood JM; Ernstoff MS; Duray PH; Gerich B
J Nucl Med; 1987 Sep; 28(9):1441-6. PubMed ID: 3476691
[TBL] [Abstract][Full Text] [Related]
32. A comparison of the cyclic anhydride and mixed anhydride methods for 111In-DTPA chelation to monoclonal antibodies.
Wang TS; Srivastava SC; Fawwaz RA; Giacomini P; Ferrone S; Richards P; Hardy M; Alderson PO
Nuklearmedizin; 1984 Aug; 23(4):193-5. PubMed ID: 6483630
[TBL] [Abstract][Full Text] [Related]
33. Localization of pulmonary human sarcoma xenografts in athymic nude mice with indium-111-labeled monoclonal antibodies.
Greager JA; Chao TC; Blend MJ; Atcher RW; Gansow OA; Brechbiel MW; Das Gupta TK
J Nucl Med; 1990 Aug; 31(8):1378-83. PubMed ID: 2384807
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the distribution and binding of monoclonal antibodies labeled with 131-iodine or 111-indium.
Buchsbaum D; Randall B; Hanna D; Chandler R; Loken M; Johnson E
Eur J Nucl Med; 1985; 10(9-10):398-402. PubMed ID: 4006981
[TBL] [Abstract][Full Text] [Related]
35. Antibodies labeled with metallic radionuclides: influence of nuclide chemistry on dose distribution.
Vaughan AT; Yankuba SC; Anderson P
NCI Monogr; 1987; (3):141-4. PubMed ID: 3029601
[TBL] [Abstract][Full Text] [Related]
36. Tumor model studies of 131I-tetracycline and other compounds.
Chauncey DM; Halpern SE; Hagan PL; Alazraki NP
J Nucl Med; 1976 Apr; 17(4):274-81. PubMed ID: 1255253
[TBL] [Abstract][Full Text] [Related]
37. Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part II. Comparison of immunoreactivity and biodistribution of monoclonal antibodies labeled with the 67Ga-chelate or with 131I.
Matzku S; Schuhmacher J; Kirchgessner H; Brüggen J
Eur J Nucl Med; 1986; 12(8):405-12. PubMed ID: 3792375
[TBL] [Abstract][Full Text] [Related]
38. An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgG.
Furukawa T; Fujibayashi Y; Fukunaga M; Saga T; Endo K; Yokoyama A
J Nucl Med; 1991 May; 32(5):825-9. PubMed ID: 2022990
[TBL] [Abstract][Full Text] [Related]
39. Comparative serum stability of radiochelates for antibody radiopharmaceuticals.
Cole WC; DeNardo SJ; Meares CF; McCall MJ; DeNardo GL; Epstein AL; O'Brien HA; Moi MK
J Nucl Med; 1987 Jan; 28(1):83-90. PubMed ID: 3794813
[TBL] [Abstract][Full Text] [Related]
40. Radiolabeled antibody: iodine versus radiometal chelates.
Anderson WT; Strand M
NCI Monogr; 1987; (3):149-51. PubMed ID: 3469527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
